![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Adis International
ISSN: 1173-5503
Source: PharmacoEconomics and Outcomes News, Vol.1, Iss.512, 2006-01, pp. : 5-5
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Bosentan potentially cost effective in PAH
Inpharma, Vol. 1, Iss. 1556, 2006-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Long-term bosentan effective in paediatric PAH
Inpharma, Vol. 1, Iss. 1505, 2005-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Initiating inhaled iloprost for PAH cost effective in Spain
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 653, 2012-01 ,pp. :